GlassScriptPhysician profile
Stefan M Zechowy
NPI 1184724171
$1,908.56
in general payments reported to CMS, 2019-2025
14 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $185 · 2021: $368 · 2022: $467 · 2023: $243 · 2024: $179 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $573.99 | 2021-2025 | Nucala |
| Alk-Abello, INC | $220.33 | 2019-2022 | |
| Aerin Medical INC. | $216.31 | 2019-2022 | |
| Optinose US, INC. | $210.19 | 2019-2025 | |
| Intersect Ent, INC. | $125.09 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $121.11 | 2021-2025 | Dupixent |
| Genzyme Corporation | $103.56 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $81.34 | 2021-2023 | |
| Stryker Corporation | $76.48 | 2021-2023 | Audion Et Dilation System |
| Integra Lifesciences Corporation | $63.56 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Smith+Nephew, INC. | $44.98 | 2021-2025 | Tula |
| Medtronic, INC. | $37.04 | 2022-2023 | Sonicision |
| Cochlear Americas | $19.44 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Acacia Pharma INC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Zechowy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.